Home-Based Exercise for Heart Failure
(MOVE-LVAD II Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how a home-based exercise program using mobile technology can benefit individuals with a new HeartMate 3 left ventricular assist device (LVAD). The researchers aim to determine if this exercise program can improve physical activity, muscle strength, and quality of life compared to usual care. Participants will either follow a guided exercise plan using a smartphone app or maintain their normal daily routine. This trial suits individuals living at home with a newly implanted HeartMate 3 LVAD who can walk independently and have a smartphone with internet access. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could enhance daily life for LVAD patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this home-based exercise program using mobile technology is safe for patients with a HeartMate 3 left ventricular assist device?
Research has shown that exercising at home with mobile technology is generally safe for people with heart conditions. A review of studies found that patients with heart disease respond well to these programs. Participants typically exercise at home using digital tools like fitness watches and smartphone apps, which assist them in following their exercise plans.
Another study found that mobile health (mHealth) technology can safely help people develop exercise habits. This technology enables patients to exercise independently and share their progress with healthcare providers. This approach not only tracks exercise but also ensures it is done safely.
In summary, using mobile technology to guide home exercise appears to be a safe and effective option for people with heart conditions, including those with heart devices.12345Why are researchers excited about this trial?
Researchers are excited about the home-based exercise program for heart failure because it utilizes mobile technology to provide a personalized and flexible approach to exercise. Unlike traditional cardiac rehab programs that require in-person attendance, this program leverages activity-tracking watches and smartphone apps to guide and progress exercise routines at home. This method not only enhances accessibility for patients who may struggle with transportation or time constraints but also encourages consistent physical activity, which is crucial for improving heart health. By integrating technology, this exercise program offers a modern, convenient, and potentially more sustainable way to manage heart failure symptoms.
What evidence suggests that this home-based exercise program using mobile technology is effective for heart failure patients with a newly implanted HeartMate 3 LVAD?
Research shows that home-based exercise programs using mobile technology can effectively boost physical activity and fitness in heart patients. In this trial, participants in the Exercise Intervention arm will follow such a program, which studies have shown to improve fitness levels as effectively as traditional supervised programs. Specifically, past participants demonstrated better walking ability, an important measure of fitness. Additionally, mobile technology aids in maintaining exercise routines by providing guidance and tracking progress. Overall, home-based exercise programs offer a promising way to improve health in patients with heart conditions.23678
Who Is on the Research Team?
Himabindu Vidula, MD
Principal Investigator
University of Pennsylvania
Are You a Good Fit for This Trial?
This trial is for adults over 18 who've just had a HeartMate 3 LVAD implanted and can walk on their own (even with help from a device). They must have a smartphone with internet because the exercise program uses mobile tech. It's for those going home or living at home with the LVAD within 45 days after leaving the hospital.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline assessments including daily step measurement, six-minute walk test, frailty testing, and CT scan for muscle mass evaluation
Treatment
Participants are randomized to either the exercise intervention or usual care. The exercise group receives personalized exercise prescriptions and remote monitoring, while the usual care group is encouraged to increase walking
Follow-up
Participants are monitored for safety and effectiveness after treatment, including questionnaires, six-minute walk testing, frailty testing, and CT scans
What Are the Treatments Tested in This Trial?
Interventions
- Home-Based Exercise Program Using Mobile Technology
Trial Overview
The study looks at how well patients do on a home-based exercise program using their smartphones compared to usual care after getting an HM3 LVAD. Researchers want to see if this improves physical activity, reduces frailty, increases muscle mass, and betters quality of life.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
The usual care group will be encouraged to increase daily walking activity as they tolerate, while complying with any activity restrictions from their clinical team. The Physical Activity Guidelines for Americans recommend increasing daily walking activity as tolerated to an average of 30 minutes daily, 5 times a week.
The exercise intervention focuses on walking and strengthening exercises with a standardized protocol to guide exercise prescription and exercise progression based on data obtained from the activity tracking watch and smartphone app.
Home-Based Exercise Program Using Mobile Technology is already approved in United States for the following indications:
- Improvement of physical activity and capacity in patients with HeartMate 3 LVAD
- Reduction of frailty and muscle mass loss in patients with HeartMate 3 LVAD
- Enhancement of quality of life in patients with HeartMate 3 LVAD
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Published Research Related to This Trial
Citations
Effectiveness of home-based cardiac rehabilitation ...
This study aims to assess the effects of mHealth HBCR interventions compared with usual care and CBCR in patients with heart disease.
Effectiveness of Home-Based Cardiac Rehabilitation ...
A 6-week home-based CR program with exercise readjustment using a mobile app can potentially enhance exercise capacity as effectively as verbal supervision.
Rehabilitation at Home Using Mobile Health for Older ...
This randomized clinical trial investigates whether a home-based mobile health cardiac rehabilitation intervention improves 6-minute walk ...
Long-term effects of 3-month home-based cardiac ...
This follow-up study found that the initial improvements in exercise tolerance and physical frailty status observed after 3-month ICT-based HBCR ...
Mobile Technology Improves Adherence to Cardiac ...
We found that adjunctive use of mobile technology is significantly associated with improved adherence to cardiac rehabilitation and number of attended sessions.
Use of mHealth Technology for Improving Exercise ...
The results show some preliminary evidence of the feasibility of using mHealth technology for building exercise adherence in patients with HF.
Effectiveness, safety and adherence of home-based ...
This systematic review aims to investigate the safety, effectiveness and adherence of home-based exercise rehabilitation in patients with coronary heart ...
Digital Technologies in Cardiac Rehabilitation: A Science ...
In remote CR, patients exercise independently and can use digital technology to monitor exercise and then transmit those data to clinicians for ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.